MedCity News September 1, 2020
Cheryl Rodenfels

The Covid-19 pandemic has impacted every facet of our society — how we work, live, learn, and play — and normalcy will not return until we find a proven vaccine. While multiple pharmaceutical and biotech companies have raced to develop a cure, a viable vaccine might still be a year out.

While we’re searching for a cure, the Covid-19 vaccine race has opened up a broader conversation about drug discovery and how we can leverage our technology resources to accelerate it. Covid-19 came on suddenly and without warning, and global epidemics are becoming more frequent, coinciding with factors like urbanization and climate change.

Technology companies have a role to help accelerate a path to discovery by providing pharmaceutical and biotech...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Analytics, Big Data, Biotechnology, Cloud, Govt Agencies, Health IT, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Technology
CDC: Thanks in part to fewer COVID-19 deaths, life expectancy rises slightly from 2021 to 2022
The art of the pandemic
Report recommends strengthening U.S. readiness for smallpox, related threats
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
Drinking water linked to 214 outbreaks in 5 years: CDC

Share This Article